Nutrition and Cancer

Aitziber Buqué is currently a Post-Doctoral Associate with the Galluzzi Lab, in the Department of Radiation Oncology at Weill Cornell Medical College (New York), where she investigates innate and acquired mechanisms of resistance to immunotherapy in HR+ breast cancer and radiotherapy as a means to overcome them. Prior to joining the Galluzzi Lab (2018), Aitziber was a Post-Doctoral Associate with the Kroemer Lab in the Cordeliers Research Center (Paris, France; 2014-2018), after receiving her M.Sc. in Bioinformatics and Computational Biology (2006) from the Complutense University (Madrid, Spain) and her Ph.D. in Biomedicine (2013) from the BioCruces Research Institute (Barakaldo, Spain). Aitziber has a long-standing interest in the immunological mechanisms controlling cancer progression and response to treatment. Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology.Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals:OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.

• Emergent impact of lifestyle on tumor progression and response to therapyAitziber Buqué Martinez and Lorenzo Galluzzi1. Modifying dietary amino acids in cancer patientsJosephine Connolly-Schoonen, Steven F. Biamonte, Lorraine Danowski and David C. Montrose2. Targeting amino acid metabolism in cancerLucie Safrhansova, Katerina Hlozkova and Julia Starkova3. Fasting mimicking diet in cancer therapyMaira Di Tano and Valter D. Longo4. Fasting and cancer responses to therapyJosé Manuel Bravo-San Pedro and Federico Pietrocola5. Autophagy-inducing nutritional interventions in experimental and clinical oncologySebastian J. Hofer, Guido Kroemer and Oliver Kepp6. Combination strategies to target metabolic flexibility in cancerJelena Krstic, Katharina Schindlmaier and Andreas Prokesch